Selective α7-nicotinic agonists normalize inhibition of auditory response in DBA mice

Psychopharmacology

Volumn 136, Issue 4, 1998, Pages 320-327

  Stevens, Karen E ^a,c   Kem, William R ^b   Mahnir, Vladimir M ^b   Freedman, Robert ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Anabaseine; Auditory evoked reponse; GTS 21; Hippocampus; Nicotinic receptor

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; ALPHA BUNGAROTOXIN; ANABASINE; NICOTINIC RECEPTOR; 3 (4 DIMETHYLAMINOBENZYLIDENE)ANABASEINE; 3 (4 DIMETHYLAMINOCINNAMYLIDENE)ANABASEINE; 3-(2,4-DIMETHOXYBENZYLIDENE)ANABASEINE; 3-(4-DIMETHYLAMINOBENZYLIDENE)ANABASEINE; 3-(4-DIMETHYLAMINOCINNAMYLIDENE)ANABASEINE; ALPHA-BUNGAROTOXIN RECEPTOR; BENZYLIDENE DERIVATIVE; BUNGAROTOXIN RECEPTOR; DRUG DERIVATIVE; NICOTINIC AGENT; PSYCHOTROPIC AGENT; PYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EVOKED AUDITORY RESPONSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; ANIMAL; COMPARATIVE STUDY; DBA MOUSE; DRUG EFFECT; PHYSIOLOGY; STARTLE REFLEX;

ANABASINE; ANIMALS; BENZYLIDENE COMPOUNDS; MALE; MICE; MICE, INBRED DBA; NICOTINIC AGONISTS; PSYCHOTROPIC DRUGS; PYRIDINES; RECEPTORS, NICOTINIC; STARTLE REACTION;

EID: 0031596817     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050573     Document Type: Article

References (48)

1. Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R (1982) Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17:639 654
2. Adler LE, Hoffer LJ. Griffith J, Waldo MC, Freedman R (1992) Normalization of deficient auditory sensory gating in relatives of schizophrenics by nicotine. Biol Psychiatry 32: 607 616
3. Adler LE, Hoffer LJ, Wiser A, Freedman R (1993) Transient normalization of a defect in auditory sensory processing in schizophrenics following cigarette smoking. Am J Psychiatry 150: 1856 1861
4. Arendash GW, Senstock GJ, Sanberg PR, Kem W R (1995) Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Res 674:252 259
5. 3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature 388:762 763
6. Bjugstad KB, Mahnir VM, Kem WR, Socci DJ, Arendash GW (1997) Long-term treatment with GTS-21 or nicotine enhances water maze performance in aged rats without affecting the density of nicotinic receptor subtypes in cortex. Drug Dev Res (in press)
7. Bourbon WT, Will KW, Gary HE, Papanicolaou AC (1987) Habituation of auditory event-related potentials: a comparison of self-initiated and automated stimulus trains. Electroencephalogr Clin Neurophysiol 66:160 166
8. Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia. Arch Gen Psychiatary 47:181 188
9. Briggs CA, Anderson DJ, Brioni JD, Buccafusco JJ. Buckley MN, Campbell JE, Decker MW, Donnely-Roberts D, Elliot RL, Holladay MW, Jui Y-H, Jackson WJ, Kin DJB, Marsh KC, O'Neill A. Pendergast MA, Ryther KB, Sullivan JP, Arneric SP (1997) Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacol Biochem Behav 57:231 241
10. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johonson EC (1997) Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4. hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280: 346 356
11. Chini B, Raimond E, Elgoyhen AB, Moralli D, Balzaretti M, Heinemann S (1994) Molecular cloning and chromosomal localization of the human alpha 7-nicotinic receptor subunit gene (CHARNA7). Genomics 19:379 381
12. Coates RM, Kem WR, Abbott BC (1971) Isolation and structure of a hoplonemertine toxin. Toxicon 9:15 22
13. Cook JD, Ellinwood EH, Wilson WP (1968) Auditory habituation at primary cortex as a function of stimulus rate. Exp Neurobiol 21:167 175
14. Couturier S, Bertrand D, Matter JM, Hernandez MC, Bertrand S, Miller N, Valera S, Barkas T, Ballivet M (1990) A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-bungarotoxin. Neuron 5:847 856
15. Davis T, Mast T, Yoshie N, Zerlin S (1966) The slow response of the auditory cortex to auditory stimuli: recovery cycle process. Electroencephalogr Clin Neurophysiol 21:101 105
16. 125I-alpha-bungarotoxin receptor subtypes. Mol Pharmacol 47:164-71
17. Eccles JC (1969) The inhibitory pathways of the central nervous system.Thomas, Springfield, Ill.
18. Freedman R, Adler LE, Gerhardt GA, Waldo M, Baker N, Rose GM, Drebing C, Nagamoto H, Bickford-Wimer P, Franks R (1987) Neurobiological studies of sensory gating in schizophrenia. Schizophr Bull 13: 669 678
19. Freedman R, Wetmore C, Stromberg I, Leonard S, Olson L (1993) α-Bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects of growth factor expression. J Neurosci 13:1965 1975
20. Freedman R, Adler LE, Bickford PC, Byerley W, Coon H, Cullum CM, Griffith JM, Harris JG, Leonard S, Milcr C, Myles-Worsley M, Nagamoto HT, Rose G, Waldo M (1994) Schizophrenia and nicotinic receptors. Harvard Rev Psychiatry 2: 179 192
21. Freedman R, Hall M, Adler LE, Leonard S (1995) Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 38:22 33
22. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, Polymeropoulos M, Holik J, Hopkins J, Hoff M, Rosenthal J, Waldo MC, Yaw J, Young DA, Breese CR, Adams C, Patterson D, Adler LE, Kruglyak L, Leonard S. Byerley W (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Nutl Acad Sci USA 94:587 594
23. Freund RK, Jungschaffer DA, Collins AC (1990) Nicotine effects in mouse hippocampus are blocked by mecamylamine, but not other nicotinic antagonists. Brain Res 511:187 191
24. Geyer MA, Wilkinson LS. Humby T, Robbins TW (1993) Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol Psychiatry 34:361 372
25. Greenman M, McClellan TA (1991) Negative effects of a smoking ban on an inpatient psychiatry service. Hosp Commun Psychiatry 42:408 412
26. Kathman N, Engle RR (1990) Sensory gating in normals and schizophrenics: a failure to find strong P50 suppression in normals. Biol Psychiatry 27:1216 1226
27. Kem WR (1971) A study of the occurance of anabaseine in Paranemertes and other nemertines. Toxicon 9:23 32
28. Kem WR, Mahnir VM, Lin B, Prokai-Tatrai K (1996) Two primary GTS-21 metabolites are potent partial agonists at alpha7 nicotinic receptors expressed in the Xenopus oocyte. Soc Neurosci Abstr 22:268
29. Knight RT, Brailowsky D, Scabini D, Simpson GV (1985) Surface evoked potentials in the unrestrained rat: component definition. Electroencephologr Clin Neurophysiol 61:430 439
30. Luntz-Leybman V, Bickford PC, Freedman R (1992) Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res 587:130 136
31. 3 receptors expressed in Xenopus oocytes. Soc Neurosci Abs 22:1780
32. Mahnir VM, Lin B, Prokai-Tatrai K, Kem WR (1997) Pharmacokinetics and urinary excretion of DMXBA (GTS-21), a compound enhancing cognition. Biopharm Drug Dispos (in press)
33. Meyer WM, de Fiebre CM, Hunter BE, Simpkins CE, Frauworth N, de Fiebre NE (1994) Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors. Drug Dev Res 31:127 134
34. Miller CL, Bickford PC, Luntz-Leybman V, Adler LE, Gerhardt GA, Freedman R (1992) Phencyclidine and auditory sensory gating in the hippocampus of the rat. Neuropharmacology 10:1041 1048
35. Orr-Urterger A, Seldin MF, Valdini A, Beaudet AL (1995) Cloning and mapping of the mouse alpha 7-neuronal nicotinic acetylcholine receptor. Genomics 26:399 402
36. Papke RL, do Fiebre CM. Kem WR, Meyer EM (1994) The subunit specific effects of novel anabaseine-derivcd nicotinic agents. In: Giacobini E, Becker R (eds) Alzheimer disease: therapeutic strategies. Birkhäuser, Boston, pp 206 211
37. 7 antisense oligonucleotides. Soc Neurosci Abstr 19:837
38. Roth WT, Horvath TB, Pfefferbaum A, Kopell BS (1980) Event-related potentials in schizophrenics. Electroencephalogr Clin Neurophysiol 48:127 139
39. Sastry BV, Chance MB, Singh G, Horn JL, Janson VE (1995) Distribution and retention of nicotine and its metabolite, cotinine, in the rat as a function of time. Pharmacology 50:128-36
40. Stevens KE, Wear KD (1997) Normalizing effects of nicotine and a novel nicotinic agonist on hippocampal auditory gating in two animals models. Pharmacol Biochem Behav 57:869 874
41. Stevens KE, Freedman R, Collins AC, Hall M, Leonard S, Marks MJ, Rose GM (1996) Genetic correlation of hippocampal auditory evoked response and α-bungarotoxin binding in inbred mouse strains. Neuropsychopharmacology 15:152-162
42. Stevens KE, Johnson RG, Rose GM (1997) Rats reared in social isolation show schizophrenia-like changes in auditory gating. Pharmacol Biochem Behav 58:1031 1036
43. Venables PH (1964) Input dysfunction in schizophrenia. In: Maher BA (ed) Progress in experimental personality research. Academic Press, Orlando, pp 1-47
44. Venables PH (1992) Hippocampal function and schizophrenia. Experimental psychological evidence. Ann NY Acad Sci 658:111-127
45. Wheeler JW, Olubajo O, Storm CB, Duffield RM (1981) Anabaseine: venom alkaloid of Aphaenogaster ants. Science 211:1051 1052
46. Wilkinson LS, Killcross SS, Humby T, Hall FS, Geyer MA, Robbins TW (1994) Isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition. Neuropsychopharmacology 10:61-72
47. Williams M, Robinson JL (1984) Nicotinic receptors in mammalian brain. Prog Neuropsychopharmacol Biol Psychiatry 8: 769 772
48. Woodruff-Pak DS, Yong-Tong L, Kem WR (1994) A nicotinic agonist (GTS-21), eyeblink classical conditioning and nicotinic receptor binding in rabbit brain. Brain Res 645:309-317